	Synexus has purchased Research Across America (RAA) for an undisclosed sum. RAA was founded in 1989 by Dr. Jeffrey Adelglass, and has grown from a single location to multiple dedicated research sites across the U.S. Its sites have conducted over 2,000 clinical trials.

	Synexus already owns 25 research sites in 10 countries. The addition of RAA’s sites means that it can now offer extra capacity, particular U.S. market expertise and therapeutic experience.

	“Synexus already has a strong international footprint. This latest acquisition is an important one for Synexus as it marks our entry into the US market, giving us truly global capability,” noted CEO Christophe Berthoux. “We spent a great deal of time considering an appropriate partner and selected Research Across America as it has a number of synergies with the Synexus model. In addition, by adding these sites to our network we have also gained expertise in areas, such as dermatology and generics, enabling us to further support our client base.”

News

The addition of Research Across America's sites means that Synexus can now offer extra capacity, particular U.S. market expertise and therapeutic experience.